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Background. Xenon seems to be an ideal anesthetic drug. To explore if next to the antagonism at the NMDA-receptor other
molecular targets are involved, we tested the xenon requirement in short sleeping Drosophila shaker mutants and in na[har38].
Methods.T h eDrosophila melanogaster strains wildtype Canton-S, na[har38], sh102 and shmns, were raised and sleep was measured.
Based on the response of the ﬂies at diﬀerent xenon concentrations, logEC50 values were calculated. Results. The logEC50-values
for WT Canton-S were 1.671 (1.601–1.742 95%-conﬁdence intervall; n = 238; P versus sh102 > 0,05), for shmns 1.711 (1.650–1.773;
n = 242; P versus WT Canton-S > 0,05). The logEC50-value for sh102 was 1.594 (1.493–1.694; n = 261; P versus shmns > 0.05). The
logEC-value of na[har38] was 2.076 (1.619–2.532; n = 207; P versus shmns < 0.05, versus sh102 < 0.05, versus WT Canton-S < 0.05).
P values for all shaker mutants were P>0.05, while na[har38] was found to be hyposensitive compared to wildtype (P < 0.05).
Conclusions. The xenon requirement in Drosophila melanogaster is not inﬂuenced by a single gene mutation at the shaker locus,
whereas a reduced expression of a nonselective cation channel leads to an increased xenon requirement. This supports the thesis
that xenon mediates its eﬀects not only via an antagonism at the NMDA-receptor.
1.Introduction
In the last decade, the noble gas xenon has been increasingly
used for anesthesia because of its low blood-gas partition
coeﬃcient, its organ protective eﬀects, and its hemodynamic
stability [1]. Xenon mediates its eﬀects via antagonism of
theN-Methyl-D-Aspartate(NMDA)receptor,whichisoneof
the glutamate-activatedion channels. The NMDA receptor is
linked with synaptic functions like memory, pain and learn-
ing [2]. Next to this well-known mechanism at the NMDA
receptor, recent studies have focused on other molecular
targets for xenon anesthesia. The inhibition of non-NMDA
receptors[3],cellularpathwayslikecalcium-homeostasis[4],
or the activation of potassium channels is described [5]; so
there seems to be a complex mixture of targets for xenon
anesthesia including widely spread ion channels.
The fruit ﬂy Drosophila melanogaster possesses a
complex nervous system organized into circuits and also
homologue ion channels can be found. Like humans, fruit
ﬂies exposed to volatile anesthetics run through several
states of anesthesia ending in an immobile state, also the EC
50 values are comparable [6]. Many of the ion channels in
Drosophilamelanogaster areconservedacrossorganisms.The
Drosophila shaker-related gene has its vertebrate counterpart
in Kv1 [7]. The neuronal channel NALCN has a homology in
Drosophila named alpha1U [8]. The Drosophila melanogaster
shaker mutants exhibit a gene mutation in the shaker locus,
which encodes for a voltage-gated potassium channel. This
mutation becomes manifest in a short-sleeping phenotype,
so these strains sleep signiﬁcantly less than the wildtype [9].
Inapreviousstudy,wehaveshownthattheseshortsleep-
ingDrosophilamelanogaster shakermutantshadanincreased
anesthetic requirement of the volatile anesthetics isoﬂurane
and sevoﬂurane [10]. The mutant strain na[har
38]( n a r r o w
abdomen; halothane anesthesia resistance), which exhibits2 The Scientiﬁc World Journal
a reduced expression of the nonselective cation neuronal
channel NALCN [11], is known to be resistant to halothane,
methoxyﬂurane, chloroform, and trichloroethylene.
To more speciﬁcally explore the role of ion channels
in xenon anesthesia and to identify new molecular targets
for xenon, we hypothesized that mutations in the shaker
potassium channel or the NALCN neuronal channel lead to
a modiﬁed xenon requirement in Drosophila melanogaster.
2. Methods
2.1. Animals. This study was approved by the local animal
investigational committee (Christian Albrechts University
Kiel). Drosophila melanogaster was bred in the laboratory at
21◦C, 68% humidity, on yeast, dark corn syrup, and agar
food. For determination of sleep and wakefulness, male and
femalefruitﬂieswereusedinequalnumbers.Toexcludeage-
associated eﬀects, only young ﬂies (≤2w e e k s )w e r et e s t e df o r
allexperiments[12].Drosophilastocksusedweresh
mns,sh
102,
na[har
38], and wild-type Canton-S. To remove modiﬁers,
stocks were consequently outcrossed for at least ﬁve rounds
to Canton-S background as described before [13].
2.2. Determination of Locomotor Activity. Sleep and wake-
fulness were determined from individual fruit ﬂies placed
in a Drosophila activity monitor system (DAMS, Trikinetics,
Waltham, MA, USA) at constant environmental conditions.
Male and female ﬂies were used in equal numbers. Activity
measurement was recorded for consecutive one-minute
periods for one week after one day of adaptation and
analyzed with custom-designed software developed in our
laboratory. As described before, sleep was deﬁned as any
period of uninterrupted behavioural immobility (0 counts
per minute) lasting >5m i n u t e s[ 14]. The total duration of
sleep episodes was then calculated exactly to the minute.
2.3. Measurement of Anesthetic Sensitivity. Anesthetic sen-
sitivity was tested in a custom-made Drosophila anesthesia
chamber (V =200mLs) connected to xenon with a constant
ﬂow of 1L·min−1. For each experiment, at least 10 young
(≤2 weeks) wild-type or mutant strain fruit ﬂies were placed
inside the chamber and exposed to xenon concentrations
from 20 to 80%. After a 10-minute exposure, the chamber
was rotated and shaken for 2 seconds under the control of
a motor, which caused the ﬂies to fall from their current
position to the bottom of the chamber. Anesthetized ﬂies
stayed immobile. With this accepted method to deprive sleep
[14], we were able to distinguish between physiological sleep
and anesthesia. The numbers of mobile and immobile ﬂies
were counted by a blinded observer, whereas a convulsion
was not considered a movement. The results were recorded
for subsequent statistical analysis. All experiments were
carried out at constant environmental temperature of 21◦C,
and concentrations of xenon were continuously monitored
at the chamber outﬂow with an oxygen monitor (Dr¨ ager
Medical AG & Co. KG, L¨ ubeck, Germany).
2.4. Statistical Analysis. Student’s t-test was used to assess
statistically signiﬁcant diﬀerences for periods of sleep and
wakefulness between Drosophila strains. Based on the
response of the ﬂies at diﬀerent concentrations of xenon,
concentration-response curves were generated. Data were
imported into GraphPad Prism (GraphPad Software, San
Diego, CA, USA), and a nonlinear regression analysis was
performed for log(dose) versus normalized response with
variable Hill slope. Resulting logEC50 was further analyzed
with one-way ANOVA and Bonferroni posttest. The half-
maximum eﬀective concentration (EC50) values and 95%
conﬁdence intervals were calculated and compared for
statistically signiﬁcant diﬀerences.
3. Results
The daily sleep amount in Drosophila melanogaster WT
Canton-S (n = 64) was 965 ± 15 minutes (mean±SEM),
sh
mns (n = 32) slept 595 ± 45 minutes, sh
102 (n = 32)
slept 764 ± 39 minutes. Compared to WT Canton-S, both
Shaker mutants were mini-sleepers (P<0.01), so the short-
sleeping phenotype was expressed as expected. The mutant
strain na[har
38]( n = 32) slept 998 ± 29 minutes, so the
daily sleep amount was comparable to the wildtype, as it was
described before.
Theanestheticrequirementofxenonwascalculatedfrom
the response of the ﬂies at diﬀerent concentrations of xenon
(20–80%).
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(1.601–1.742 95%-conﬁdence intervall; n = 238; P versus
sh
102 > 0.05), for sh
mns 1.711 (1.650–1.773; n = 242; P versus
WT Canton-S >0,05). The logEC50 value for sh
102 was 1.594
(1.493–1.694; n = 261; P versus sh
mns > 0.05). So there was
no statistically signiﬁcant diﬀerence in the xenon require-
ment of both shaker stocks compared to the wildtype. The
logEC value of na[har
38] was 2.076 (1.619–2.532; n = 207; P
versus sh
mns < 0.05, versus sh
102 < 0.05, versus WT Canton-S
<0.05).Sona[har
38] wasfoundtobehyposensitive toxenon
compared to all other tested strains. Fitted curves are shown
inFigure 1,andlogEC50valuesareshowninFigure 2.X enon
had a signiﬁcant higher EC50 value in na[har
38]ﬂ i e s .
4. Discussion
Whereas intravenous anesthetics act via speciﬁc receptor-
ligand interactions, other drugs like the volatile anesthetics
or the inert gas xenon act via less well-known pathways.
In contrast to the volatile anesthetics, the eﬀects of xenon
were mainly attributed to the NMDA receptor subtype of the
glutamatereceptors[15].Xenonisknowntobeanantagonist
at the NMDA-receptor, while it has only little eﬀects on the
GABA-A receptor [2]. Younger molecular studies focused on
other molecular targets for xenon anesthesia:xenon precon-
ditioningwasdiscoveredtobedependentontheactivationof
adenosine triphosphate-sensitive potassium channels [5]. In
Caenorhabditis elegans, a non-NMDA-receptor was required
for eﬀects of xenon anesthesia [3]. In 2004, Gruss et al.
described the two-pore domain potassium channel TREK-1
as a novel target for xenon anesthesia [16]. These channels
are members of the two-pore-domain potassium channelThe Scientiﬁc World Journal 3
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Figure1:Percentageofanesthetizedﬂiesatdiﬀerentconcentrations
ofxenon.Dotsshowtheactualmeasureddatapoints;linesshowthe
best-ﬁt sigmoidal curve for these data points. Note that the y-axis
has a logarithmic scale.
Figure 2: logEC50 of xenon for diﬀerent strains of ﬂies (mean ±
SE). The logEC50 in na[har
38] ﬂies is signiﬁcantly higher than in
the other three groups.
family. For this reason, we chose well-known Drosophila
strains with a point-mutation in a gene, which encodes
for the alpha subunit of a tetrameric voltage-dependent
potassium channel and which is responsible for membrane
repolarization after an incoming action potential [17]. We
used the two strains sh
mns and sh
102, which are strong
alleles of the shaker gene with loss-of-function proteins [6].
Electrophysiological and molecular studies found out that in
theseanimalstheshakerpotassiumchanneliscompletelynot
expressed [18, 19], so we were able to avoid an interaction of
xenon with reduced Shaker currents, as they appear in weak
alleles.
For the volatile anesthetics isoﬂurane, and sevoﬂurane,
we described an increased requirement for these drugs in
Drosophila shaker mutants, due to this single nucleotide
mutation [10]. In the present study, we found no statistically
signiﬁcant diﬀerence in the anesthetic requirement of xenon
in sh
mns and sh
102. Therefore, it might be concluded that the
shakerpotassiumchannelisnotargetforxenonanesthesiain
Drosophila melanogaster or at least that the action of xenon
on the shaker channel has no consequences for anesthetic
potency. As a matter of course, the eﬀects of xenon could be
causedbytheactivationofotherpotassiumchannelslikeshal
or shab.
In the next step, we focussed on the na[har
38] strain.
These ﬂies have reduced expression of the nonselective neu-
ronal ion channel NALCN, which is permeably for sodium-,
potassium-, and calcium ions, and which contributes to rest-
ing sodium permeability [11]. In the absence of anesthetics,
these ﬂies show a characteristic walking behavior, although
they are viable and fertile [20]. In na[har
38] fruit ﬂies used in
this study, a reduced expression of the NALCN ion channel
provoked altered sensitivities to halothane, isoﬂurane, and
sevoﬂurane [10, 21, 22]. For xenon, we demonstrated an
increased anesthetic requirement comparedto wild-type and
shaker strains. Apart from the eﬀects of potassium, this
might be a consequence of a changed basal excitability of
the nervous system due to changed sodium or calcium
permeabilities as a result of modiﬁed NALCN channels. The
calcium homeostasis is especially part of the theory which
tries to explain the anesthetic eﬀects of volatile anesthetics.
In clinical concentrations, xenon and other anesthetic
gases inhibit the calcium ATPase pump activity [23], which
is responsible for the maintenance of the calcium concen-
tration gradient. Assumed that xenon interacts with the
glutamate-dependent NMDA receptor, it is conceivable that
the known process of the calcium inﬂux and the sodium
and potassium eﬄux after a depolarization at the NMDA-
receptor is hampered by a changed calcium and/or sodium
homeostasis.
Drosophilamelanogaster isafrequentlyutilizedmodelfor
studiesinvestigatingthemechanismsofanesthesiabecauseof
itshomologousionchannels,receptors,orneurotransmitters
[8], although there are limitations of our study. The relative
short exposure of 10 minutes of xenon anesthesia may
neglect other pharmacodynamic eﬀects, but in view of the
low blood-gas partition coeﬃcient of xenon, it is acceptable
to assume that the ﬂies reached a steady-state. Another
limitationofourdataisthechoiceoftheanestheticendpoint:
lookingatanotherendpointmayleadtodiﬀerentresults,like
it was shown for an anesthesia with halothane in na[har
38]
[21, 22].
Our study shows that a single gene mutation in a
voltage-gated potassium channel has no eﬀect on the xenon
requirement in Drosophila melanogaster, whereas a mutation
in the nonselective ion channel NALCN actually has. This
leads to the assumption that the shaker potassium channel
is not a molecular target for xenon anesthesia.
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